Based on the STERIS plc stock forecast from 3 analysts, the average analyst target price for STERIS plc is USD 260.71 over the next 12 months. STERIS plc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of STERIS plc is Slightly Bullish , which is based on 9 positive signals and 7 negative signals. At the last closing, STERIS plc’s stock price was USD 221.04. STERIS plc’s stock price has changed by +5.99% over the past week, -2.47% over the past month and +11.07% over the last year.
No recent analyst target price found for STERIS plc
No recent average analyst rating found for STERIS plc
Company Overview STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio. Read Less
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated en...Read More
Frequently Asked Questions About STERIS plc (STE) Stock
Based on ratings from 3 analysts STERIS plc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and hold ratings.
STE stock's dividend yield is 1.03%.
Our analysis grades STE stock's dividend yield at F. This means that STE stock's dividend yield is above 33% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this STE may be a poor dividend stock for its sector.
Based on targets from 3 analysts, the average taret price for STE is USD 260.71 over the next 12 months. The maximum analyst target price is USD 265 while the minimum anlayst target price is USD 240.
STE stock's Price/Earning ratio is 35.44.
Our analysis grades STE stock's Price / Earning ratio at F. This means that STE stock's Price/Earning ratio is above 52% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this STE may be a overvalued for its sector.
The last closing price of STE's stock was USD 221.04.
The most recent market capitalization for STE is USD 22.15B.
Based on targets from 3 analysts, the average taret price for STE is projected at USD 260.71 over the next 12 months.
This means that STE's stock price may go up by +17.95% over the next 12 months.
We can't find any ETFs which contains STERIS plc's stock.
As per our most recent records STERIS plc has 18,000 Employees.
STERIS plc's registered address is 5960 Heisley Road, Mentor, OH, United States, 44060.
You can get more information about it from STERIS plc's website at https://www.steris.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About STERIS plc (STE) Stock
Based on ratings from 3 analysts STERIS plc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and hold ratings.
STE stock's dividend yield is 1.03%.
Our analysis grades STE stock's dividend yield at F. This means that STE stock's dividend yield is above 33% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this STE may be a poor dividend stock for its sector.
Based on targets from 3 analysts, the average taret price for STE is USD 260.71 over the next 12 months. The maximum analyst target price is USD 265 while the minimum anlayst target price is USD 240.
STE stock's Price/Earning ratio is 35.44.
Our analysis grades STE stock's Price / Earning ratio at F. This means that STE stock's Price/Earning ratio is above 52% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this STE may be a overvalued for its sector.
The last closing price of STE's stock was USD 221.04.
The most recent market capitalization for STE is USD 22.15B.
Based on targets from 3 analysts, the average taret price for STE is projected at USD 260.71 over the next 12 months.
This means that STE's stock price may go up by +17.95% over the next 12 months.
We can't find any ETFs which contains STERIS plc's stock.
As per our most recent records STERIS plc has 18,000 Employees.
STERIS plc's registered address is 5960 Heisley Road, Mentor, OH, United States, 44060.
You can get more information about it from STERIS plc's website at https://www.steris.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for STE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
